Takeaway
- A meta-analysis finds that pharmacotherapy specifically with combined noradrenergic plus antimuscarinic agents is safe and efficacious for lessening the severity of obstructive sleep apnea (OSA).
Why this matters
- No pharmacotherapy currently enjoys routine use for OSA.
Study design
- Systematic review and meta-analysis of 9 randomized controlled trials (RCTs) involving 154...